Remote Monitoring of CGM Data in Pediatric Diabetes: Real-World Case Studies
- Annette Pergamo CPNP-PC, RN, CDCES
- 3 days ago
- 4 min read

Continuous glucose monitoring has transformed pediatric diabetes management by providing real-time, dynamic insights into glucose trends. When paired with proactive outreach from a specialized care team, CGMs enable a shift from reactive to proactive care. For children and adolescents, whose insulin requirements are in constant flux, this approach allows for early pattern identification and guided interventions before issues escalate.
At SweetSpot, we believe that data alone isn't the solution; it’s the bridge to better education, reduced family burden, and the reassurance that no one has to manage this complex condition alone.
Case Study 1: Rebuilding Confidence and Smoothing Trends
When Maya, an 10-year-old using an automated insulin delivery (AID) system, first joined SweetSpot, her Time in Range (TIR) was 55%. Her reports showed a "rollercoaster" pattern: sharp highs followed by rapid drops. These fluctuations were largely driven by delayed bolusing and the overtreatment of hypoglycemia. Maya’s family told me that they felt they were constantly "chasing" the numbers.
The SweetSpot Intervention
Over several months of regular check-ins, I worked with Maya and her mother to:
Integrate Pre-bolusing: I moved beyond just "telling" them to bolus early and instead developed practical routines to make it a seamless part of their day.
Address Overtreatment: I focused on how to appropriately treat lows on an AID to prevent rebound hyperglycemia.
Support the Caregiver: Maya’s mother was hesitant to adjust doses due to a deep fear of hypoglycemia. By developing a rapport and closely monitoring reports, I was able to reassure her as we gradually strengthened Maya’s carb ratios.
The Results
The knowledge that an expert was keeping a watchful eye between scheduled visits gave Maya's mother the confidence to make necessary changes. After six months, Maya’s TIR improved from 55% to 75%. The "rollercoaster" smoothed out, and Maya’s mother expressed a profound sense of relief.
Case Study 2: Overcoming Insulin Resistance through Advocacy
Leo, a 19-year-old, began his SweetSpot journey with a TIR of 45%. Despite a high total daily dose (TDD) of 100 units, his glucose remained persistently elevated. Leo was frustrated; he felt that even when he "did the right thing," the insulin simply wasn't working.
The SweetSpot Intervention
Recognizing a pattern of insulin resistance in my regular reviews of Leo’s CGM data, I initiated a transparent discussion with Leo and his father about potential clinical solutions.
Clinical Coordination: I empowered Leo’s father with the data he needed to discuss insulin resistance with their healthcare provider at their next appointment.
Behavioral Motivation: As his insulin became more effective, Leo felt motivated to bolus more consistently. I encouraged his father to focus on positive reinforcement, which is a powerful driver for teenagers.
The Results
With the right medication and behavioral support, Leo’s insulin requirements dropped from 100 to 82 units per day, and his TIR improved to 63%. This case highlights how remote monitoring can uncover underlying clinical issues that might otherwise be missed between office visits.
Case Study 3: Navigating the "Honeymoon" and New Diagnosis
Ethan is a 15-year-old who was diagnosed with Type 1 Diabetes just three months before enrolling in our program. Initially, he was in the "honeymoon phase," maintaining a TIR above 80% with minimal effort. However, as his body’s insulin production declined, his numbers began to climb and stay high.
The SweetSpot Intervention
As Ethan’s glucose patterns shifted, his family reached out to me in a state of concern. I supported them by:
Real-Time Education: I guided them through the transition out of the honeymoon phase, adjusting insulin doses frequently as requirements increased.
Just-in-Time Learning: When I noticed Ethan’s blood sugar running >250 for several hours, we reviewed ketone management. When he started baseball season, we pivoted to sports-related hypoglycemia prevention.
Emotional Support: Ethan was struggling with the anger and frustration of a new diagnosis. I provided the family with strategies to navigate these behaviors with support rather than punishment.
The Results
Ethan went from being overwhelmed to actively engaging in his own care, even asking thoughtful questions during group calls with his parents between visits with his provider. He maintained a TIR >70% throughout the entire transition. This collaboration fostered a sense of ownership in Ethan.
The Bigger Picture
These stories demonstrate that a CGM is far more than a tracking device, it is a catalyst for empowerment. Whether we are addressing glycemic variability, insulin resistance, or the emotional toll of a new diagnosis, SweetSpot’s model provides:
Rapid Identification of clinical needs through regular data review.
Direct Outreach before complications or frustrations escalate.
True Extension-of-Clinic Support that reinforces education when it is most relevant.
Data alone doesn't fix problems. Advocacy, education, and coordinated care do.
If you’d like to see how SweetSpot can support your patients and their families, reach out to info@sweetspot.health.
-------
SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care.
SweetSpot combines a centralized software platform for managing diabetes device data, such as data from CGMs and insulin pumps, with wrap-around clinical support services. SweetSpot’s virtual team of Certified Diabetes Care and Education Specialists (CDCES) performs monthly CGM data reviews and coordinates with providers and patients to facilitate treatment plan changes. By actively managing and remotely reviewing CGM data between patient visits, we ensure patients receive timely treatment adjustments to improve glycemic control and patient outcomes.
Additionally, SweetSpot’s automated capture of reimbursable care events optimizes CPT code utilization, unlocking new revenue streams for practices and making our partnerships both clinically effective and financially profitable.